Insider Transactions in Q3 2021 at Immunity Bio, Inc. (IBRX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2021
|
Richard Adcock CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,273
-4.72%
|
$38,457
$9.95 P/Share
|
|
Sep 09
2021
|
Richard Adcock CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
8,620
+8.7%
|
-
|
|
Sep 09
2021
|
David C. Sachs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,598
+22.31%
|
-
|
|
Aug 23
2021
|
Cheryl Cohen Director |
SELL
Open market or private sale
|
Direct |
14,801
-6.87%
|
$148,010
$10.12 P/Share
|
|
Aug 20
2021
|
Cheryl Cohen Director |
SELL
Open market or private sale
|
Direct |
9,976
-4.43%
|
$99,760
$10.0 P/Share
|
|
Aug 18
2021
|
Cheryl Cohen Director |
SELL
Open market or private sale
|
Direct |
2,133
-0.94%
|
$21,330
$10.03 P/Share
|
|
Aug 17
2021
|
Cheryl Cohen Director |
SELL
Open market or private sale
|
Direct |
43,398
-16.02%
|
$433,980
$10.12 P/Share
|